FFA
IMNM icon

Farther Finance Advisors’s Immunome IMNM Stock Holding History

Farther Finance Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316 Sell
15
-1,984
-99% -$42.5K ﹤0.01% 5627
2026
Q1 		$44.9K Buy
1,999
+1,984
+13,227% +$44.2K ﹤0.01% 3070
2025
Q4 		$322 Buy
+15
New +$263 ﹤0.01% 5119
2025
Q2 		– Sell
-100
Closed -$626 – 4577
2025
Q1 		$626 Hold
100
– – ﹤0.01% 3738
2024
Q4 		$1.06K Hold
100
– – ﹤0.01% 3233
2024
Q3 		$1.46K Hold
100
– – ﹤0.01% 3108
2024
Q2 		$1.22K Hold
100
– – ﹤0.01% 2996
2024
Q1 		$2.21K Hold
100
– – ﹤0.01% 2449
2023
Q4 		$1.07K Hold
100
– – ﹤0.01% 2696
2023
Q3 		$835 Hold
100
– – ﹤0.01% 2124
2023
Q2 		$791 Hold
100
– – ﹤0.01% 2037
2023
Q1 		$499 Hold
100
– – ﹤0.01% 2006
2022
Q4 		$221 Buy
+100
New +$403 ﹤0.01% 2021

Other funds holding IMNM

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's IMNM Position: Q2 2026 in Review

Farther Finance Advisors reduced its Immunome (IMNM) stake by 99% in Q2 2026, selling an estimated $42.5K and leaving 15 shares worth $316. The position accounts for ﹤0.01% of the portfolio, ranked #5627.

Farther Finance Advisors first reported a position in IMNM in Q4 2022 and has held it in 13 quarters since. The position peaked at $44.9K in Q1 2026. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Farther Finance Advisors held 15 shares of Immunome worth $316 as of Q2 2026.
  • Farther Finance Advisors sold 1,984 Immunome shares in Q2 2026, an estimated $42.5K.
  • Immunome made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5627 holding.
  • Farther Finance Advisors first reported a position in Immunome in Q4 2022 and has held it in 13 quarters since.
  • Farther Finance Advisors's Immunome position peaked at $44.9K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.